The Dodgers Post podcast has raised questions regarding Shohei Ohtani’s knee issues and how it might impact his performance with the Los Angeles Dodgers. Baseball writers Dylan Hernandez and Jack Harris debated whether the Dodgers should adopt a more cautious approach concerning Ohtani’s workload, especially after their recent series sweep by the Arizona Diamondbacks. Ohtani’s knee problem has already led to him missing the 2026 MLB All-Star Game and a scheduled pitching start, as the Dodgers plan a knee-draining procedure followed by a likely pain-relief injection.
Ohtani remains active as a designated hitter, but the persistent knee issue has been a concern since he exited a game against the Pittsburgh Pirates in June. Despite manager Dave Roberts downplaying the severity, the situation has prompted the Dodgers to carefully manage Ohtani’s pitching appearances, aiming to preserve him for a potential World Series run. This cautious strategy appears reflected in market movements, with implications for Ohtani’s MVP prospects and his ability to lead the MLB in runs scored for the 2026 season.
Key Takeaways
- Markets suggest Ohtani’s knee issue could reduce his MVP chances, with current pricing at 85% YES for him winning the 2026 NL MVP, down from 88% a week ago.
- Concerns over Ohtani’s health appear to influence his odds of leading the MLB in runs, now priced at 11% YES from a previous 24%.
- The Dodgers’ preemptive measures with Ohtani’s knee are consistent with preserving his performance for the season’s second half.
What to Watch
Observers should monitor the Dodgers’ management of Ohtani’s playing time and any further announcements regarding his health. The team’s approach to his workload could impact his performance metrics and market odds. Additionally, watch for Ohtani’s return to pitching and potential changes in his role that might affect his MVP and runs leader prospects. Developments in these areas could further influence market pricing.
Get live prediction-market analysis, powered by Vera. Sign up for Vera.